Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 9/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.64 |
| ▸ | MEN1 | O00255 | 7/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 6/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.64 |
| ▸ | RECQL | P46063 | 5/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.64 |
| ▸ | HPGD | P15428 | 4/20 | 0.64 |
| ▸ | BLM | P54132 | 3/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.64 |
| ▸ | TP53 | P04637 | 3/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.64 |
| ▸ | RAF1 | P04049 | 2/20 | 0.64 |
| ▸ | MAP2K1 | Q02750 | 2/20 | 0.64 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.64 |
| ▸ | HSPD1 | P10809 | 2/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29601012 | 1.00 | MAPT (0.64) | MAPTALDH1A1MEN1KMT2AMAPK1 | |
| Elliptinone SCHEMBL29929970 | 0.89 | MAPT (0.62) | MAPTALDH1A1MEN1KMT2AMAPK1 | |
| SCHEMBL19449185 | 0.85 | MAPT (0.59) | MAPTALDH1A1MEN1KMT2AMAPK1 | |
| SCHEMBL10401558 | 0.80 | MAPT (0.62) | MAPTALDH1A1MEN1KMT2AMAPK1 | |
| Maritinone SCHEMBL29514700 | 0.79 | MAPT (0.81) | MAPTALDH1A1MEN1KMT2AMAPK1 | |
| Maritinone SCHEMBL15661147 | 0.79 | MAPT (0.81) | MAPTALDH1A1MEN1KMT2AMAPK1 | |
| SCHEMBL18971787 | 0.78 | MAPT (0.51) | MAPTALDH1A1MEN1KMT2AMAPK1 | |
| SCHEMBL16478887 | 0.78 | ALDH1A1 (0.51) | MAPTALDH1A1MEN1KMT2AMAPK1 | |
| Plumbagin SCHEMBL34186 | 0.78 | MAPT (1.00) | MAPTALDH1A1MEN1KMT2AMAPK1 | |
| Plumbagin SCHEMBL29386213 | 0.78 | MAPT (1.00) | MAPTALDH1A1MEN1KMT2AMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011086285-A1 | COMPOSITION FOR DYEING KERATIN FIBRES INCLUDING AT LEAST ONE ORTHO-DIPHENOL DERIVATIVE, AND OXIDISING AGENT, A CLAY AND AN ALKALISING AGENT | L'OREAL (FR) | 2011-07-21 | — | — | WO | claimed |
| EP-4362892-B1 | COMPOSITION COMPRISING AT LEAST ONE ALKYL (POLY)GLYCOSIDE, AT LEAST ONE FATTY ALCOHOL, AT LEAST ONE FATTY ACID, AND AT LEAST ONE ALKALINE AGENT | OREAL (FR) | 2026-04-15 | — | — | EP | disclosed |
| US-12533311-B2 | Method for dyeing keratin fibres starting from isatin and from powder and/or dye extract of indigo-producing plants | L'OREAL (FR) | 2026-01-27 | — | — | US | disclosed |
| US-20250387309-A1 | METHOD FOR THE TREATMENT OF KERATIN FIBRES COMPRISING A PRETREATMENT OR POST-TREATMENT STEP | OREAL (FR) | 2025-12-25 | — | — | US | disclosed |
| EP-4452203-B1 | PROCESS FOR DYEING KERATIN FIBRES USING A COSMETIC COMPOSITION COMPRISING PROPANE-1,3-DIOL AND A DYEING COMPOSITION | OREAL (FR) | 2025-12-24 | — | — | EP | disclosed |
| US-20250375366-A1 | PROCESS FOR TREATING KERATIN FIBRES USING A CARNITINE SALT OR A CARNITINE DERIVATIVE | OREAL (FR) | 2025-12-11 | — | — | US | disclosed |
| US-12472136-B2 | Composition comprising at least one alkyl (poly)glycoside, at least one fatty alcohol, at least one fatty acid, and at least one alkaline agent | L'OREAL (FR) | 2025-11-18 | — | — | US | disclosed |
| US-12453683-B2 | Composition comprising at least nonionic surfactant, 1,3-propanediol, at least one fatty substance, at least one colouring agent | L'OREAL (FR) | 2025-10-28 | — | — | US | disclosed |
| US-12453686-B2 | Cosmetic composition comprising at least one alkyl (poly)glycoside, N,N-dicarboxymethylglutamic acid, propane-1,3-diol, at least one fatty substance other than fatty acids, at least one dye | L'OREAL (FR) | 2025-10-28 | — | — | US | disclosed |
| US-20250302715-A1 | COMPOSITION COMPRISING N,N-DICARBOXYMETHYLGLUTAMIC ACID, AT LEAST ONE FATTY ALCOHOL, AT LEAST ONE FATTY ACID, AT LEAST ONE POLYOL, AT LEAST ONE ALKALINE AGENT AND OPTIONALLY AT LEAST ONE DYE | L'OREAL (FR) | 2025-10-02 | — | — | US | disclosed |
| WO-2016091817-A1 | HAIR DYEING PROCESS USING AT LEAST ONE DYE, AN ORGANIC TITANIUM SALT, AND A NON-CELLULOSIC-BASED POLYSACCHARIDE | L'OREAL (FR) | 2016-06-16 | — | — | WO | disclosed |
| CN-105288129-A | Traditional Chinese medicine composition for preventing and treating nephrotic syndrome and preparation method thereof | LI LIANQING | 2016-02-03 | — | — | CN | disclosed |
| CN-105288043-A | Preparation for treating nephrotic syndrome and preparing method | LI LIANQING | 2016-02-03 | — | — | CN | disclosed |
| WO-2015086677-A1 | HAIR DYEING PROCESS USING AT LEAST ONE ORTHO-DIPHENOL AND ONE ORGANIC SALT OF TITANIUM AND OF A CARBOXYLIC ACID | L'OREAL (FR) | 2015-06-18 | — | — | WO | disclosed |
| WO-2015086678-A1 | HAIR DYEING METHOD EMPLOYING AT LEAST ONE ORTHO-DIPHENOL, ONE TITANIUM DERIVATIVE AND ONE CARBOXYLIC ACID | L'OREAL (FR) | 2015-06-18 | — | — | WO | disclosed |
| EP-2723306-A2 | HAIR DYEING PROCESS USING AT LEAST ONE ORTHO-DIPHENOL, A MANGANESE OR ZINC SALT, HYDROGEN PEROXIDE, (BI)CARBONATE, AN ALKALINE AGENT AND A TITANIUM OR SCANDIUM SALT | L'Oréal (FR) | 2014-04-30 | — | — | EP | disclosed |
| WO-2012175683-A2 | HAIR DYEING PROCESS USING AT LEAST ONE ORTHO-DIPHENOL, A MANGANESE OR ZINC SALT, HYDROGEN PEROXIDE, (BI)CARBONATE, AN ALKALINE AGENT AND A TITANIUM OR SCANDIUM SALT | L'OREAL (FR) | 2012-12-27 | — | — | WO | disclosed |
| WO-2011157666-A1 | COSMETIC USE OF A NATURAL EXTRACT DERIVED FROM BEETROOT PEEL FOR DYEING HAIR COMPOSITION COMPRISING THE EXTRACT, AN OXIDIZING AGENT, A BASIFYING AGENT AN OPTIONAL METALLIC DERIVATIVE | L'OREAL (FR) | 2011-12-22 | — | — | WO | disclosed |
| WO-2011086285-A1 | COMPOSITION FOR DYEING KERATIN FIBRES INCLUDING AT LEAST ONE ORTHO-DIPHENOL DERIVATIVE, AND OXIDISING AGENT, A CLAY AND AN ALKALISING AGENT | L'OREAL (FR) | 2011-07-21 | — | — | WO | disclosed |
| CN-101112406-A | Medicinal plant plumbago indica having antitumor effect | GUANGDONG MEDICAL COLLEGE (CN) | 2008-01-30 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250375366-A1 | PROCESS FOR TREATING KERATIN FIBRES USING A CARNITINE SALT OR A CARNITINE DERIVATIVE | KRT18, CRAT, CKMT1A; CKMT1B | MAPT 93/4885ALDH1A1 2728/4885MEN1 2783/4885 |
| US-20250387309-A1 | METHOD FOR THE TREATMENT OF KERATIN FIBRES COMPRISING A PRETREATMENT OR POST-TREATMENT STEP | PROC, KRT18, VCL | MAPT 2850/4885ALDH1A1 3170/4885MEN1 4597/4885 |
| US-20250302715-A1 | COMPOSITION COMPRISING N,N-DICARBOXYMETHYLGLUTAMIC ACID, AT LEAST ONE FATTY ALCOHOL, AT LEAST ONE FATTY ACID, AT LEAST ONE POLYOL, AT LEAST ONE ALKALINE AGENT AND OPTIONALLY AT LEAST ONE DYE | KRT18, DSG1, FPGS | MAPT 416/4885ALDH1A1 395/4885MEN1 3621/4885 |
| US-12533311-B2 | Method for dyeing keratin fibres starting from isatin and from powder and/or dye extract of indigo-producing plants | KRT18, CUTA, KRTCAP2 | MAPT 115/4885ALDH1A1 2507/4885MEN1 4820/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.